FundedIQ
Biotechnology

Xilis: Funding, Investors & Team (Oct 2026)

Xilis is an oncology and accuracy wellbeing organization that analyze disease and tracks down the right treatment. The organization utilizes "miniature organoids" to make great many 3D reproductions of a patient's growth in around six days, which the organization says can be utilized for testing for drug similarity quicker. It was established in 2019 and is settled in Durham, North Carolina.

xilis.com LinkedIn Durham, United States 11-50 employees
Biotechnology Health Care Health Diagnostics Life Science Pharmaceutical
Total raised
$19.0M
Rounds
1
Latest
Series A
Jul 2022

Xilis has raised $19.0M across 1 funding round on record, the most recent a Series A of $19.0M announced in Jul 2022.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Xilis Company Profile and Key Stats

Total funding raised
$19.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$19.0M in Jul 2022
Employees
11-50
reported band
Headquarters
Durham, United States

Latest funding round on record: Jul 2022.

Xilis Funding Rounds

Date
Round
Amount
Series A
$19.0M

Xilis Founders and Leadership Team

Name
Role
Contact
David Hsu
Founder
Locked

Contact details for the Xilis team: 1 of 1 has an email address on file.

Start 14-day free trial →

Xilis Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
8,558
$15M

Xilis' latest round of $19.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Xilis in Biotechnology and Durham

Companies Similar to Xilis

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Xilis Funding FAQs

What does Xilis do?

Xilis is an oncology and accuracy wellbeing organization that analyze disease and tracks down the right treatment. The organization utilizes "miniature organoids" to make great many 3D reproductions of a patient's growth in around six days, which the organization says can be utilized for testing for drug similarity quicker. It was established in 2019 and is settled in Durham, North Carolina.

How much funding has Xilis raised?

Xilis has raised $19.0M across 1 round on record. The most recent is a Series A of $19.0M announced in Jul 2022.

When did Xilis last raise funding?

Xilis' most recent funding round on record is a Series A of $19.0M, announced in Jul 2022.

Who founded Xilis?

FundedIQ lists David Hsu (Founder) at Xilis.

Where is Xilis headquartered?

Xilis is based in Durham, North Carolina, United States.

How many employees does Xilis have?

Xilis is in the 11-50 employee band.

How does Xilis' funding compare to other Biotechnology startups?

Xilis' latest round of $19.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Xilis Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Xilis is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.